Pill Identifier App

Reaphirm Plant Source DHA

Generic Name: prenatal supplement
Dosage Form: capsule, gelatin coated

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Product Information.

Contraindications

Reaphirm Plant Source DHA is contraindicated in patients with hypersensitivity to any of its components or color additives.

Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.

Iron Therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.

Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (Vitamin B12).

Refer to MM1carton label


Boxed Warning

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.  Keep this product out of the reach of children.  In case of accidental overdose, call a doctor or a Poison Control Center immediately.

WARNINGS/PRECAUTIONS:

Reaphirm Plant Source DHA should be used with caution in patients with known sensitivity or allergy to soy.

Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kigney stones.  High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues.  Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.

Iodine should be used with caution in patients with an overactive thyroid.

Prolonged use of iron salts may produce iron storage disease.

Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive.

The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.

Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding.  Supplemental intake of omega-3 fatty acids such as DHA exceeding 2 grams per day is not recommended.

Avoid Overdosage.  Keep out of the reach of children.

Drug Interactions:

Medications for an overactive thyroid (anti-thyroid drugs) used in conjunction with iodine supplementation may lead to hypothyroidism.

Medications for hypertension used in conjunction with iodine supplementation may increase potassium.

High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs.

Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.

Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions.

Consult appropriate references for additional specific vitamin-drug interactions.

Information for Patients: Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.

Pediatric Use: Not for pediatric use. 


Adverse Reactions

Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Reaphirm Plant Source DHA.  Reported adverse events include skin ailments, gastrointestinal complaints, glucose abnormalities, and visual problems.

Dosage and Administration

Before, during and after pregnancy, one softgel capsule daily, or as directed by a physician.

How Supplied

Reaphirm Plant Source DHA is available as a dark blue, oval shaped softgel capsule imprinted "EV3010".  Available in Box of Unit-Dose pack of 30 (5 child resistant blister cards of 6 softgel capsules).

Store at room temperature, approximately 15-30C (59-86F), avoid excessive heat.

Rx Only

Manufactured for

EVERETT LABORATORIES, INC.


West Orange, NJ 07052

1-877-324-9349

Principal Display Panel

reaphirm111128carton_lcr

Reaphirm Plant Source DHA 
prenatal supplement capsule, gelatin coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0642-3010
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Vitamin A (Beta Carotene) Beta Carotene 1100 [iU]
Ascorbic Acid (Ascorbic Acid) Ascorbic Acid 30 mg
Thiamine Mononitrate (Thiamine ) Thiamine Mononitrate 1.6 mg
Riboflavin (Riboflavin) Riboflavin 1.8 mg
Niacin (Niacinamide) Niacinamide 15 mg
Pyridoxine Hydrochloride (Pyridoxine) Pyridoxine 2.5  mg
Cyanocobalamin (Cyanocobalamin) Cyanocobalamin .012 mg
Folic Acid (Folic Acid) Folic Acid 1 mg
Iodine (Iodine) Iodine 0.150 mg
Magnesium (Magnesium Oxide) Magnesium Oxide 20 mg
Zinc (Zinc Oxide) Zinc Oxide 25 mg
Copper (Cupric Oxide) Cupric Oxide 2 mg
Vitamin D (Cholecalciferol) Cholecalciferol 1000 [iU]
Omega-3 Fatty Acids (Doconexent) Doconexent 200 mg
Vitamin E (Alpha-Tocopherol) Alpha-Tocopherol 20 [iU]
Iron (Iron) Iron 29 mg
Inactive Ingredients
Ingredient Name Strength
Gelatin  
Sorbitol  
Glycerin  
Soybean Oil  
Water  
Yellow Wax  
Anhydrous Dibasic Calcium Phosphate  
Lecithin, Soybean  
Titanium Dioxide  
Sodium Thiosulfate  
Sunflower Oil  
Tocopherol  
Ascorbyl palmitate  
Caramel  
FD&C Blue NO. 1  
Corn Oil  
Product Characteristics
Color blue (Dark Blue) Score no score
Shape OVAL (size 12 Oval Capsule) Size 10mm
Flavor Imprint Code EV3010
Contains         
Packaging
# Item Code Package Description
1 NDC:0642-3010-30 5 BLISTER PACK (BLISTER PACK) in 1 BOX
1 6 CAPSULE, GELATIN COATED (CAPSULE) in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 12/05/2011
Labeler - Everett Laboratories, Inc. (071170534)
Registrant - Everett Laboratories, Inc. (071170534)
Revised: 11/2011
 
Everett Laboratories, Inc.



Hide
(web1)